Arachidonic acid metabolism in human prostate cancer

International Journal of Oncology

Volumn 41, Issue 4, 2012, Pages 1495-1503

  Yang, Peiying ^a   Cartwright, Carrie A ^a   Li, Jin ^a   Wen, Sijin ^a   Prokhorova, Ina N ^a   Shureiqi, Imad ^a   Troncoso, Patricia ^a   Navone, Nora M ^a   Newman, Robert A ^a   Kim, Jeri ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Arachidonic acid; Cyclooxygenase; Eicosanoid; Lipoxygenase; Prostate cancer; Xenograft

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 2; ICOSANOID; LIPOXYGENASE; MESSENGER RNA; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL STRAIN LNCAP; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ANDROGENS; ARACHIDONIC ACID; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOXYGENASES; MALE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RNA, MESSENGER; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866524565     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1588     Document Type: Article

References (48)

1. Baade PD, Youlden DR and Krnjacki LJ: International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 53: 171-184, 2009.
2. Coleman MP, Quaresma M, Berrino F, et al: Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9: 730-756, 2008.
3. Crowe FL, Key TJ, Appleby PN, et al: Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 87: 1405-1413, 2008.
4. Bidoli E, Talamini R, Bosetti C, et al: Macronutrients, fatty acids, cholesterol and prostate cancer risk. Ann Oncol 16: 152-157, 2005.
5. Rose DP and Connolly JM: Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 18: 243-254, 1991.
6. Pandalai PK, Pilat MJ, Yamazaki K, Naik H and Pienta KJ: The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res 16: 815-820, 1996.
7. Chaudry AA, Wahle KW, McClinton S and Moffat LE: Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors. Int J Cancer 57: 176-180, 1994.
8. Anderson KM, Wygodny JB, Ondrey F and Harris J: Human PC-3 prostate cell line DNA synthesis is suppressed by eicosatetraynoic acid, an in vitro inhibitor of arachidonic acid metabolism. Prostate 12: 3-12, 1988.
9. Berquin IM, Min Y, Wu R, et al: Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest 117: 1866-1875, 2007.
10. Higgs GA, Moncada S and Vane JR: Eicosanoids in inflammation. Ann Clin Res 16: 287-299, 1984.
11. Wallace JM: Nutritional and botanical modulation of the inflammatory cascade-eicosanoids, cyclooxygenases, and lipoxygenases - as an adjunct in cancer therapy. Integr Cancer Ther 1: 7-37, 2002.
12. Hughes-Fulford M, Chen Y and Tjandrawinata RR: Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells. Carcinogenesis 22: 701-707, 2001.
13. Subbarayan V, Sabichi AL, Llansa N, Lippman SM and Menter DG: Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res 61: 2720-2726, 2001.
14. Tang K and Honn KV: 12(S)-HETE in cancer metastasis. Adv Exp Med Biol 447: 181-191, 1999.
15. Yin B, Yang Y, Zhao Z, et al: Arachidonate 12-lipoxygenase may serve as a potential marker and therapeutic target for prostate cancer stem cells. Int J Oncol 38: 1041-1046, 2011.
16. Ghosh J and Myers CE: Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA 95: 13182-13187, 1998.
17. Tang S, Bhatia B, Maldonado CJ, et al: Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem 277: 16189-16201, 2002.
18. Shureiqi I, Chen D, Lee JJ, et al: 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst 92: 1136-1142, 2000.
19. Vanaja DK, Grossmann ME, Celis E and Young CY: Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta12,14- prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells. Cancer Res 60: 4714-4718, 2000.
20. Wang MT, Honn KV and Nie D: Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 26: 525-534, 2007.
21. Dassesse T, de Leval X, de Leval L, Pirotte B, Castronovo V and Waltregny D: Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage. Eur Urol 50: 1021-1031, 2006.
22. Nie D, Guo Y, Yang D, et al: Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho. Cancer Res 68: 115-121, 2008.
23. Nie D, Che M, Zacharek A, et al: Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility. Am J Pathol 164: 429-439, 2004.
24. Wang X, Colby JK, Yang P, Fischer SM, Newman RA and Klein RD: The resistance to the tumor suppressive effects of COX inhibitors and COX-2 gene disruption in TRAMP mice is associated with the loss of COX expression in prostate tissue. Carcinogenesis 29: 120-128, 2008.
25. Shappell SB, Olson SJ, Hannah SE, et al: Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Res 63: 2256-2267, 2003.
26. Shappell SB, Manning S, Boeglin WE, et al: Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma. Neoplasia 3: 287-303, 2001.
27. Bhatia B, Maldonado CJ, Tang S, et al: Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants. J Biol Chem 278: 25091-25100, 2003.
28. Navone NM, Olive M, Ozen M, et al: Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res 3: 2493-2500, 1997.
29. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
30. Shureiqi I, Zuo X, Broaddus R, et al: The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J 21: 743-753, 2007.
31. Kempen EC, Yang P, Felix E, Madden T and Newman RA: Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Biochem 297: 183-190, 2001.
32. Yang P, Felix E, Madden T, Fischer SM and Newman RA: Quantitative high-performance liquid chromatography/electrospray ionization tandem mass spectrometric analysis of 2- and 3-series prostaglandins in cultured tumor cells. Anal Biochem 308: 168-177, 2002.
33. Yang P, Chan D, Felix E, et al: Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids. Prostaglandins Leukot Essent Fatty Acids 75: 385-395, 2006.
34. Yang P, Collin P, Madden T, et al: Inhibition of proliferation of PC3 cells by the branched-chain fatty acid, 12-methyltetra-decanoic acid, is associated with inhibition of 5-lipoxygenase. Prostate 55: 281-291, 2003.
35. Dahiya R, Yoon WH, Boyle B, Schoenberg S, Yen TS and Narayan P: Biochemical, cytogenetic, and morphological characteristics of human primary and metastatic prostate cancer cell lines. Biochem Int 27: 567-577, 1992.
36. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR and Heston WD: Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87: 1456-1462, 1995.
37. Angelucci A, Garofalo S, Speca S, et al: Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells. Endocr Relat Cancer 15: 91-100, 2008.
38. Zha S, Gage WR, Sauvageot J, et al: Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Cancer Res 61: 8617-8623, 2001.
39. Kirschenbaum A, Klausner AP, Lee R, et al: Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology 56: 671-676, 2000.
40. Larre S, Tran N, Fan C, et al: PGE2 and LTB4 tissue levels in benign and cancerous prostates. Prostaglandins Other Lipid Mediat 87: 14-19, 2008.
41. Wang H, Wang X, Zeng A and Yang K: Effects of coherence on anisotropic electromagnetic Gaussian-Schell model beams on propagation. Opt Lett 32: 2215-2217, 2007.
42. Gao LJ, Wang XF, Yang HY, Gao XZ, Lu YC and Cui ZJ: Effects of a lactic acid bacteria community SFC-2 treated on rice straw. Huan Jing Ke Xue 28: 1392-1396, 2007 (In Chinese).
43. Timar J, Raso E, Dome B, et al: Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. Int J Cancer 87: 37-43, 2000.
44. Nie D, Hillman GG, Geddes T, et al: Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Cancer Res 58: 4047-4051, 1998.
45. Kelavkar UP, Harya NS, Hutzley J, et al: DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Prostaglandins Other Lipid Mediat 82: 185-197, 2007.
46. Kelavkar UP, Parwani AV, Shappell SB and Martin WD: Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. Neoplasia 8: 510-522, 2006.
47. Shappell SB, Boeglin WE, Olson SJ, Kasper S and Brash AR: 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma. Am J Pathol 155: 235-245, 1999.
48. Gonzalez AL, Roberts RL, Massion PP, Olson SJ, Shyr Y and Shappell SB: 15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation. Hum Pathol 35: 840-849, 2004.